{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T19:40:28Z","timestamp":1720726828592},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00266-024-03873-x","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T20:01:51Z","timestamp":1709582511000},"page":"2545-2552","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cutaneous Melanoma and 486 Human Blood Metabolites: A Mendelian Randomization Study"],"prefix":"10.1007","volume":"48","author":[{"given":"Xuanchen","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiguang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"issue":"3","key":"3873_CR1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1","volume":"23","author":"ER Sauter","year":"1998","unstructured":"Sauter ER, Herlyn M (1998) Molecular biology of human melanoma development and progression. Mol Carcinog 23(3):132\u201343","journal-title":"Mol Carcinog"},{"issue":"6","key":"3873_CR2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/ajcp\/110.6.788","volume":"110","author":"A Slominski","year":"1998","unstructured":"Slominski A, Wortsman J, Nickoloff B, McClatchey K, Mihm MC, Ross JS (1998) Molecular pathology of malignant melanoma. Am J Clin Pathol 110(6):788\u2013794","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"3873_CR3","first-page":"1005","volume":"28","author":"M Rastrelli","year":"2014","unstructured":"Rastrelli M, Tropea S, Rossi CR, Alaibac M (2014) Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo 28(6):1005\u201311","journal-title":"In Vivo"},{"issue":"4","key":"3873_CR4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1615\/CritRevEukaryotGeneExpr.2020028454","volume":"30","author":"B Ahmed","year":"2020","unstructured":"Ahmed B, Qadir MI, Ghafoor S (2020) Malignant melanoma: skin cancer-diagnosis, prevention, and treatment. Crit Rev Eukaryot Gene Expr 30(4):291\u2013297","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"18","key":"3873_CR5","doi-asserted-by":"crossref","first-page":"18479","DOI":"10.1002\/cam4.6448","volume":"12","author":"S Wang","year":"2023","unstructured":"Wang S, Chen Y, Sun J, Mo R, Tan Q (2023) Development and validation of two online dynamic nomograms for patients with non-distant metastatic cutaneous melanoma based on surgical approaches. Cancer Med 12(18):18479\u201390","journal-title":"Cancer Med"},{"issue":"4","key":"3873_CR6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3322\/caac.21670","volume":"71","author":"DR Schmidt","year":"2021","unstructured":"Schmidt DR, Patel R, Kirsch DG, Lewis CA, Vander Heiden MG, Locasale JW (2021) Metabolomics in cancer research and emerging applications in clinical oncology. CA Cancer J Clin 71(4):333\u201358","journal-title":"CA Cancer J Clin"},{"key":"3873_CR7","doi-asserted-by":"crossref","first-page":"107827","DOI":"10.1016\/j.pharmthera.2021.107827","volume":"224","author":"L Liang","year":"2021","unstructured":"Liang L, Sun F, Wang H, Hu Z (2021) Metabolomics, metabolic flux analysis and cancer pharmacology. Pharmacol Ther 224:107827","journal-title":"Pharmacol Ther"},{"issue":"7","key":"3873_CR8","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3390\/ijms21072436","volume":"21","author":"M Kosmopoulou","year":"2020","unstructured":"Kosmopoulou M, Giannopoulou AF, Iliou A, Benaki D, Panagiotakis A, Velentzas AD et al (2020) Human melanoma-cell metabolic profiling: identification of novel biomarkers indicating metastasis. Int J Mol Sci 21(7):2436","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3873_CR9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/cancers13030434","volume":"13","author":"DD Weber","year":"2021","unstructured":"Weber DD, Thapa M, Aminzadeh-Gohari S, Redtenbacher AS, Catalano L, Feichtinger RG et al (2021) Targeted metabolomics identifies plasma biomarkers in mice with metabolically heterogeneous melanoma xenografts. Cancers 13(3):434","journal-title":"Cancers"},{"issue":"2","key":"3873_CR10","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3390\/ijms24021604","volume":"24","author":"YA Hagyousif","year":"2023","unstructured":"Hagyousif YA, Sharaf BM, Zenati RA, El-Huneidi W, Bustanji Y, Abu-Gharbieh E et al (2023) Skin cancer metabolic profile assessed by different analytical platforms. Int J Mol Sci 24(2):1604","journal-title":"Int J Mol Sci"},{"issue":"7","key":"3873_CR11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrm.2016.25","volume":"17","author":"CH Johnson","year":"2016","unstructured":"Johnson CH, Ivanisevic J, Siuzdak G (2016) Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol 17(7):451\u20139","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"3873_CR12","doi-asserted-by":"crossref","first-page":"e0240849","DOI":"10.1371\/journal.pone.0240849","volume":"15","author":"NJ Taylor","year":"2020","unstructured":"Taylor NJ, Gaynanova I, Eschrich SA, Welsh EA, Garrett TJ, Beecher C et al (2020) Metabolomics of primary cutaneous melanoma and matched adjacent extratumoral microenvironment. PLoS One 15(10):e0240849","journal-title":"PLoS One"},{"issue":"8","key":"3873_CR13","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/1535-7163.MCT-12-0131","volume":"11","author":"Y Liu","year":"2012","unstructured":"Liu Y, Cao Y, Zhang W, Bergmeier S, Qian Y, Akbar H et al (2012) A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo. Mol Cancer Ther 11(8):1672\u201382","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"3873_CR14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00280-006-0291-9","volume":"59","author":"X Cao","year":"2007","unstructured":"Cao X, Fang L, Gibbs S, Huang Y, Dai Z, Wen P et al (2007) Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia. Cancer Chemother Pharmacol 59(4):495\u2013505","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"3873_CR15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000321179","volume":"35","author":"DA Bennett","year":"2010","unstructured":"Bennett DA (2010) An introduction to instrumental variables\u2013part 2: Mendelian randomisation. Neuroepidemiology 35(4):307\u2013310","journal-title":"Neuroepidemiology"},{"issue":"8","key":"3873_CR16","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27(8):1133\u201363","journal-title":"Stat Med"},{"issue":"7","key":"3873_CR17","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/jama.2019.22241","volume":"323","author":"J Elliott","year":"2020","unstructured":"Elliott J, Bodinier B, Bond TA, Chadeau-Hyam M, Evangelou E, Moons KGM et al (2020) Predictive accuracy of a polygenic risk score-enhanced prediction model versus a clinical risk score for coronary artery disease. JAMA 323(7):636\u2013645","journal-title":"JAMA"},{"issue":"6","key":"3873_CR18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/ng.2982","volume":"46","author":"SY Shin","year":"2014","unstructured":"Shin SY, Fauman EB, Petersen AK, Krumsiek J, Santos R, Huang J et al (2014) An atlas of genetic influences on human blood metabolites. Nat Genet 46(6):543\u201350","journal-title":"Nat Genet"},{"issue":"3","key":"3873_CR19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG, Collaboration CCG (2011) Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol 40(3):755\u201364","journal-title":"Int J Epidemiol"},{"issue":"11","key":"3873_CR20","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/sim.7221","volume":"36","author":"J Bowden","year":"2017","unstructured":"Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan N, Thompson J (2017) A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med 36(11):1783\u2013802","journal-title":"Stat Med"},{"issue":"5","key":"3873_CR21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG (2017) Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol 32(5):377\u201389","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"3873_CR22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S (2016) Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304\u2013314","journal-title":"Genet Epidemiol"},{"issue":"5","key":"3873_CR23","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50(5):693\u20138","journal-title":"Nat Genet"},{"issue":"Database issue","key":"3873_CR24","doi-asserted-by":"crossref","first-page":"D109","DOI":"10.1093\/nar\/gkr988","volume":"40","author":"M Kanehisa","year":"2012","unstructured":"Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M (2012) KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 40(Database issue):D109-14","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"3873_CR25","doi-asserted-by":"crossref","first-page":"W486","DOI":"10.1093\/nar\/gky310","volume":"46","author":"J Chong","year":"2018","unstructured":"Chong J, Soufan O, Li C, Caraus I, Li S, Bourque G et al (2018) MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res 46(W1):W486\u2013W94","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"3873_CR26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2133.1988.tb03198.x","volume":"119","author":"G Vescovi","year":"1988","unstructured":"Vescovi G, Weber B, Matrat M, Ramacci C, Nabet P, Kremer B (1988) Modulation by palmitoyl-carnitine of calcium activated, phospholipid-dependent protein kinase activity and inhibition of melanoma cell growth. Br J Dermatol 119(2):171\u2013178","journal-title":"Br J Dermatol"},{"issue":"2","key":"3873_CR27","first-page":"125","volume":"52","author":"VN Sumantran","year":"2015","unstructured":"Sumantran VN, Mishra P, Sudhakar N (2015) Microarray analysis of differentially expressed genes regulating lipid metabolism during melanoma progression. Indian J Biochem Biophys 52(2):125\u201331","journal-title":"Indian J Biochem Biophys"},{"key":"3873_CR28","doi-asserted-by":"crossref","first-page":"949745","DOI":"10.3389\/fphar.2022.949745","volume":"13","author":"C Yan","year":"2022","unstructured":"Yan C, Wu D, Gan L, Wang J, Yang W, Xu B (2022) Significant metabolic alterations in non-small cell lung cancer patients by epidermal growth factor receptor-targeted therapy and PD-1\/PD-L1 immunotherapy. Front Pharmacol 13:949745","journal-title":"Front Pharmacol"},{"issue":"1","key":"3873_CR29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13287-018-0792-6","volume":"9","author":"Z Lin","year":"2018","unstructured":"Lin Z, Liu F, Shi P, Song A, Huang Z, Zou D et al (2018) Fatty acid oxidation promotes reprogramming by enhancing oxidative phosphorylation and inhibiting protein kinase C. Stem Cell Res Ther 9(1):47","journal-title":"Stem Cell Res Ther"},{"key":"3873_CR30","volume":"12","author":"R Dong","year":"2021","unstructured":"Dong R, Ye N, Zhao S, Wang G, Zhang Y, Wang T et al (2021) Studies on novel diagnostic and predictive biomarkers of intrahepatic cholestasis of pregnancy through metabolomics and proteomics. Front Immunol 12:733225","journal-title":"Front Immunol"},{"issue":"4","key":"3873_CR31","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jcjd.2017.09.002","volume":"42","author":"FZ Bouchouirab","year":"2018","unstructured":"Bouchouirab FZ, Fortin M, Noll C, Dube J, Carpentier AC (2018) Plasma palmitoyl-carnitine (AC16:0) is a marker of increased postprandial nonesterified incomplete fatty acid oxidation rate in adults with type 2 diabetes. Can J Diabetes 42(4):382\u20138","journal-title":"Can J Diabetes"},{"issue":"6","key":"3873_CR32","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/jn\/135.6.1510","volume":"135","author":"U Wenzel","year":"2005","unstructured":"Wenzel U, Nickel A, Daniel H (2005) Increased carnitine-dependent fatty acid uptake into mitochondria of human colon cancer cells induces apoptosis. J Nutr 135(6):1510\u20134","journal-title":"J Nutr"},{"issue":"6","key":"3873_CR33","doi-asserted-by":"crossref","first-page":"C1278","DOI":"10.1152\/ajpcell.00319.2019","volume":"317","author":"PC Turnbull","year":"2019","unstructured":"Turnbull PC, Hughes MC, Perry CGR (2019) The fatty acid derivative palmitoylcarnitine abrogates colorectal cancer cell survival by depleting glutathione. Am J Physiol Cell Physiol 317(6):C1278\u2013C1288","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"3873_CR34","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2015.49","volume":"5","author":"S Beloribi-Djefaflia","year":"2016","unstructured":"Beloribi-Djefaflia S, Vasseur S, Guillaumond F (2016) Lipid metabolic reprogramming in cancer cells. Oncogenesis 5(1):e189","journal-title":"Oncogenesis"},{"issue":"1","key":"3873_CR35","doi-asserted-by":"crossref","first-page":"112275","DOI":"10.1016\/j.yexcr.2020.112275","volume":"396","author":"Y Fu","year":"2020","unstructured":"Fu Y, Rathod D, Patel K (2020) Protein kinase C inhibitor anchored BRD4 PROTAC PEGylated nanoliposomes for the treatment of vemurafenib-resistant melanoma. Exp Cell Res 396(1):112275","journal-title":"Exp Cell Res"},{"issue":"1","key":"3873_CR36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0197-0186(02)00067-0","volume":"42","author":"J Sobiesiak-Mirska","year":"2003","unstructured":"Sobiesiak-Mirska J, Na\u0142ecz MJ, Na\u0142ecz KA (2003) Interaction of palmitoylcarnitine with protein kinase C in neuroblastoma NB-2a cells. Neurochem Int 42(1):45\u201355","journal-title":"Neurochem Int"},{"issue":"5","key":"3873_CR37","first-page":"517","volume":"9","author":"AJ Alberg","year":"2000","unstructured":"Alberg AJ, Gordon GB, Hoffman SC, Comstock GW, Helzlsouer KJ (2000) Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer. Cancer Epidemiol Biomark. Prev. 9(5):517\u201321","journal-title":"Cancer Epidemiol Biomark. Prev."},{"issue":"6a","key":"3873_CR38","first-page":"4051","volume":"21","author":"AJ Alberg","year":"2001","unstructured":"Alberg AJ, Gordon GB, Genkinger JM, Hoffman SC, Selvin E, Comstock GW et al (2001) Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and risk of melanoma or squamous cell carcinoma of the skin. Anticancer Res 21(6a):4051\u20134","journal-title":"Anticancer Res"},{"issue":"4","key":"3873_CR39","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3892\/ijo.2012.1588","volume":"41","author":"P Yang","year":"2012","unstructured":"Yang P, Cartwright CA, Li J, Wen S, Prokhorova IN, Shureiqi I et al (2012) Arachidonic acid metabolism in human prostate cancer. Int J Oncol 41(4):1495\u2013503","journal-title":"Int J Oncol"},{"issue":"5","key":"3873_CR40","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.18632\/oncotarget.2994","volume":"6","author":"J Chang","year":"2015","unstructured":"Chang J, Jiang L, Wang Y, Yao B, Yang S, Zhang B et al (2015) 12\/15 Lipoxygenase regulation of colorectal tumorigenesis is determined by the relative tumor levels of its metabolite 12-HETE and 13-HODE in animal models. Oncotarget 6(5):2879\u20132888","journal-title":"Oncotarget"},{"key":"3873_CR41","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.2147\/CMAR.S180334","volume":"10","author":"Q Liu","year":"2018","unstructured":"Liu Q, Tan W, Che J, Yuan D, Zhang L, Sun Y et al (2018) 12-HETE facilitates cell survival by activating the integrin-linked kinase\/NF-kappaB pathway in ovarian cancer. Cancer Manag Res 10:5825\u201338","journal-title":"Cancer Manag Res"},{"issue":"5","key":"3873_CR42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00008390-200209000-00003","volume":"12","author":"I Winer","year":"2002","unstructured":"Winer I, Normolle DP, Shureiqi I, Sondak VK, Johnson T, Su L et al (2002) Expression of 12-lipoxygenase as a biomarker for melanoma carcinogenesis. Melanoma Res 12(5):429\u201334","journal-title":"Melanoma Res"},{"issue":"3\u20134","key":"3873_CR43","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00666105","volume":"13","author":"KV Honn","year":"1994","unstructured":"Honn KV, Tang DG, Gao X, Butovich IA, Liu B, Timar J et al (1994) 12-lipoxygenases and 12(S)-HETE: role in cancer metastasis. Cancer Metastasis Rev 13(3\u20134):365\u201396","journal-title":"Cancer Metastasis Rev"},{"issue":"12","key":"3873_CR44","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.ejca.2013.03.030","volume":"49","author":"KH Kang","year":"2013","unstructured":"Kang KH, Ling TY, Liou HH, Huang YK, Hour MJ, Liou HC et al (2013) Enhancement role of host 12\/15-lipoxygenase in melanoma progression. Eur J Cancer. 49(12):2747\u201359","journal-title":"Eur J Cancer."},{"issue":"10400","key":"3873_CR45","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","volume":"402","author":"GV Long","year":"2023","unstructured":"Long GV, Swetter SM, Menzies AM, Gershenwald JE, Scolyer RA (2023) Cutaneous melanoma. Lancet 402(10400):485\u2013502","journal-title":"Lancet"},{"issue":"1","key":"3873_CR46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.det.2022.07.017","volume":"41","author":"S Rashid","year":"2023","unstructured":"Rashid S, Shaughnessy M, Tsao H (2023) Melanoma classification and management in the era of molecular medicine. Dermatol Clin 41(1):49\u201363","journal-title":"Dermatol Clin"}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-024-03873-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00266-024-03873-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-024-03873-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T19:02:51Z","timestamp":1720724571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00266-024-03873-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":46,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["3873"],"URL":"https:\/\/doi.org\/10.1007\/s00266-024-03873-x","relation":{},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"value":"0364-216X","type":"print"},{"value":"1432-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,4]]},"assertion":[{"value":"19 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"For this type of study, informed consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}